Skip to main content
. Author manuscript; available in PMC: 2013 May 7.
Published in final edited form as: Mol Pharm. 2012 Mar 28;9(5):1449–1458. doi: 10.1021/mp3000259

Figure 3.

Figure 3

Luciferase assay: All MTS-EGFP-p53 and MTS-EGFP-p53 NLS mutation constructs were tested for their ability to activate a p53 reporter in A) T47D cells and B) MCF-7 cells. EGFP-p53 serves as a positive control and EGFP as a negative control. All constructs were corrected to EGFP-p53 control, which is set at 100%. Statistical analysis was performed by using one-way ANOVA with Tukey’s post test. **p<0.005 and ***p<0.0005 compared to EGFP-p53.